FDA to Speed Biosimilar Approvals in Push to Cut Drug Costs

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President Donald Trump’s aggressive agenda to lower costs for medicines in the US.

Texas Returns to Keller Postman to Link Tylenol to Child Autism

Texas is turning again to Keller Postman, a firm that helped the state secure a $1.4 billion settlement with Meta, as it tries to link Tylenol with an increased risk of autism.

Trump’s Surgeon General Pick to Parry Concerns She’s Unqualified

Casey Means, President Donald Trump’s pick for US Surgeon General, aims to quell concerns over her perceived lack of medical experience during a Congressional hearing on her nomination later this week.

US Fires Health Official Who Opposed Widely Used Covid Shots

A top biosecurity adviser at the Department of Health and Human Services who believed messenger RNA Covid vaccines should be taken off the market was fired over the weekend, an agency official said.

Kid Lobbyist

Rare Disease Turns Massachusetts Family Into Part-Time Lobbyists

Maggie Dion, a 9-year-old from Massachusetts, dressed up as President Donald Trump for Halloween to send a lobbying message to Washington as part of her family’s push to renew a lapsed law that gives financial incentives to bio-pharmaceutical companies to develop treatments for the rarest pediatric conditions.

Latest Stories

Character.AI to Ban Children From Talking to Its Chatbots

Artificial intelligence startup Character.AI will ban kids from having conversations with chatbots on its platform following growing pressure from lawmakers and a raft of lawsuits alleging the company’s so-called characters are responsible for harms to children.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & PracticeEnvironment & EnergyEnvironmental, Social & Governance (ESG)The United States Law Week
  • Business & Practice
  • Environment & Energy
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Stablecoin Accounting Treatment Requires More Than Semantics

The debate over the accounting treatment of stablecoins matters not only to companies, accountants, and auditors, but also to investors, regulators, and markets. Clear financial reporting underpins investor confidence and financial stability by extension.

Covid Vaccine & Personal Data: Does HIPAA Still Matter?

EXPLORE BLOOMBERG LAW

Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: